Does AVELUMAB Cause Malignant neoplasm progression? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Malignant neoplasm progression have been filed in association with AVELUMAB (BAVENCIO). This represents 1.0% of all adverse event reports for AVELUMAB.
37
Reports of Malignant neoplasm progression with AVELUMAB
1.0%
of all AVELUMAB reports
7
Deaths
9
Hospitalizations
How Dangerous Is Malignant neoplasm progression From AVELUMAB?
Of the 37 reports, 7 (18.9%) resulted in death, 9 (24.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AVELUMAB. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does AVELUMAB Cause?
Death (361)
Disease progression (355)
Off label use (200)
Diarrhoea (153)
Infusion related reaction (142)
Pyrexia (129)
Fatigue (124)
Neoplasm progression (119)
Dyspnoea (100)
Nausea (99)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which AVELUMAB Alternatives Have Lower Malignant neoplasm progression Risk?
AVELUMAB vs AVIBACTAM
AVELUMAB vs AVIBACTAM\CEFTAZIDIME
AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE\TITANIUM DIOXIDE\ZINC
AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE
AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE